Skin conditions (dermatitis, eczema, psoriasis) decisions — 2025

The Board granted readjudication for the claims of service connection for left foot hallux valgus and tinea versicolor, but denied the claims for tinea corporis, tinea cruris, carbuncle, cyst, and scarring secondary to tinea versicolor.

The Board denied a compensable evaluation for pseudofolliculitis barbae, and denied ratings in excess of the current evaluations for left shoulder acromioclavicular joint osteoarthritis and right knee strain with limitation of flexion and extension.

The Veteran's claim for specially adapted housing was denied as he does not meet the criteria due to his ability to independently ambulate with the use of braces.

The Board granted service connection for tinea pedis and tinea unguium of both feet, resolving reasonable doubt in the Veteran's favor.

The Board denied the Veteran's claims for special monthly compensation based on aid and attendance or housebound status due to her service-connected disabilities not meeting the criteria.

The Board denied the Veteran's claims for a total disability rating based on individual unemployability (TDIU) and special monthly compensation under 38 U.S.C. § 1114(s).

The Board granted service connection for an acquired psychiatric disorder, diagnosed as major depressive disorder with anxious distress, resolving reasonable doubt in favor of the Veteran. The claims for onychomycosis and tinea pedis, right gastrocnemius tear, right shoulder pain, and TMJ joint pain and dysfunction were remanded.

The Board granted an initial rating of 10 percent for pseudofolliculitis barbae and remanded the claims for service connection for a lower back strain and sleep apnea.

The Board denied an increased rating for the Veteran's left knee and left shoulder disabilities, but granted a 10 percent rating for his bilateral tinea pedis.

The Board granted service connection for rosacea with rhinophyma and denied an increased rating for acne vulgaris with surface contour depressed on palpation.

The Board denied service connection for allergic rhinitis and chronic fatigue syndrome, denied an initial compensable rating for bilateral hearing loss disability, denied increased ratings in excess of 30 percent for chronic sinusitis, granted a 50 percent initial rating for tension headaches, and denied initial compensable ratings for dermatitis and respiratory disability (shortness of breath).

The Board denied the veteran's appeal for a higher rating for pseudofolliculitis barbae, as there was no evidence that it impacted at least 20 percent of his total body area or required systemic therapy.

The Board denied the claim for revision of an April 24, 1996, rating decision that denied service connection for psoriasis on the basis of clear and unmistakable error (CUE).

The Board granted a 10 percent disability rating for dermatitis, variously diagnosed as seborrheic dermatitis, dermatophytosis, and tinea versicolor, prior to June 5, 2023, but denied a higher rating from that date. The issues related to Raynaud's syndrome and special monthly compensation were remanded.

The Veteran withdrew the appeal for service connection for supraventricular arrhythmia, chronic paronychia, psoriasis and rosacea (claimed as skin condition), pulmonary nodules, and valvular heart disease.

The Board remands the issues of a higher rating for bilateral plantar fasciitis and service connection for pes planus, ingrown toenail of the left great toe, and tinea pedis due to procedural errors in the prior adjudication.

The Board denied the Veteran's claim for an increased rating for chronic dermatitis, as the evidence did not support a rating in excess of 10 percent.

The Board remands the claim for service connection for pseudofolliculitis barbae to obtain a new, adequate medical opinion that addresses all evidence of record.

The Board granted service connection for depressive disorder with anxiety disorder and bilateral lower extremity diabetic neuropathy, atherosclerotic cardiovascular disease, and chronic kidney disease, all secondary to diabetes mellitus. A 30 percent initial rating was granted for stasis dermatitis.

The Veteran withdrew the appeals for a rating in excess of 50 percent for obstructive sleep apnea and a compensable rating for pseudofolliculitis barbae.